{"component": "definition", "props": {"groups": [{"samples": [{"hash": "ivAv3uadd1K", "uri": "/contracts/ivAv3uadd1K#additional-technology", "label": "Development and License Agreement (Pharmathene, Inc)", "score": 24.8138256073, "published": true}, {"hash": "f01UAPGjp5O", "uri": "/contracts/f01UAPGjp5O#additional-technology", "label": "Development and License Agreement (Corixa Corp)", "score": 18.0, "published": true}, {"hash": "daMr7luwM6q", "uri": "/contracts/daMr7luwM6q#additional-technology", "label": "Development and License Agreement (Corixa Corp)", "score": 18.0, "published": true}], "snippet": "shall have the meaning set forth in Section 4.1(c).", "size": 7, "snippet_links": [], "hash": "70e1cf2f10f75614262654220da668a7", "id": 1}, {"samples": [{"hash": "eRTcHAdzjRa", "uri": "/contracts/eRTcHAdzjRa#additional-technology", "label": "License Agreement (Finch Therapeutics Group, Inc.)", "score": 32.1540031433, "published": true}, {"hash": "kFxXLwGMyEJ", "uri": "/contracts/kFxXLwGMyEJ#additional-technology", "label": "License Agreement (Finch Therapeutics Group, Inc.)", "score": 32.107460022, "published": true}], "snippet": "has the meaning set forth in Section 2.3.", "size": 3, "snippet_links": [{"key": "section-23", "type": "clause", "offset": [29, 40]}], "hash": "b3af752cdca38400971832755b37d2ba", "id": 2}, {"samples": [{"hash": "lQ8VPOSRxsw", "uri": "/contracts/lQ8VPOSRxsw#additional-technology", "label": "Technology License Agreement (Mpath Interactive Inc/Ca)", "score": 18.0, "published": true}, {"hash": "fmxOTXXjBWR", "uri": "/contracts/fmxOTXXjBWR#additional-technology", "label": "Technology License Agreement (Mpath Interactive Inc/Ca)", "score": 18.0, "published": true}], "snippet": "means and include the MCAP Protocol and all other data, information, software, or other technology as specified in Attachment A hereto, and all Improvements thereto developed by Mpath during the term of this Agreement, as well as all related Technical Documents.", "size": 2, "snippet_links": [{"key": "other-data", "type": "clause", "offset": [44, 54]}, {"key": "other-technology", "type": "clause", "offset": [82, 98]}, {"key": "as-specified", "type": "clause", "offset": [99, 111]}, {"key": "attachment-a", "type": "clause", "offset": [115, 127]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [184, 217]}, {"key": "technical-documents", "type": "definition", "offset": [242, 261]}], "hash": "349c8ef876f305158e1434bd98cdb3b2", "id": 3}, {"samples": [{"hash": "7eYZYdhGrgS", "uri": "/contracts/7eYZYdhGrgS#additional-technology", "label": "Evaluation and Commercialization Agreement (Genmab a/S)", "score": 30.4017791748, "published": true}, {"hash": "kc9pOfbenfw", "uri": "/contracts/kc9pOfbenfw#additional-technology", "label": "Evaluation and Commercialization Agreement (Genmab a/S)", "score": 30.2484607697, "published": true}], "snippet": "means the [***] (as defined in the [***]) and the [***].", "size": 2, "snippet_links": [], "hash": "2e34e98a437d65cbcf8396697a2162d7", "id": 4}, {"samples": [{"hash": "4usXOc412iv", "uri": "/contracts/4usXOc412iv#additional-technology", "label": "Asset Purchase Agreement (Finch Therapeutics Group, Inc.)", "score": 32.1540031433, "published": true}, {"hash": "eMOKTTDL3Dk", "uri": "/contracts/eMOKTTDL3Dk#additional-technology", "label": "Asset Purchase Agreement (Finch Therapeutics Group, Inc.)", "score": 32.107460022, "published": true}], "snippet": "shall have the meaning set forth in Section 7.14.", "size": 2, "snippet_links": [], "hash": "e9bca5e4850a86ec465f4c535e807c84", "id": 5}, {"samples": [{"hash": "jdj0XEmWFxN", "uri": "/contracts/jdj0XEmWFxN#additional-technology", "label": "Technology License Agreement (Mpath Interactive Inc/Ca)", "score": 18.0, "published": true}, {"hash": "iponPqFmXn4", "uri": "/contracts/iponPqFmXn4#additional-technology", "label": "Technology License Agreement (Mpath Interactive Inc/Ca)", "score": 18.0, "published": true}], "snippet": "means and include the MCAP Protocol and all other data, information, software, or other technology of Mpath and Catapult as specified in Attachment A hereto, and all Improvements thereto developed by Mpath or Catapult during the term of this Agreement, as well as all related Technical Documents.", "size": 2, "snippet_links": [{"key": "other-data", "type": "clause", "offset": [44, 54]}, {"key": "other-technology", "type": "clause", "offset": [82, 98]}, {"key": "as-specified", "type": "clause", "offset": [121, 133]}, {"key": "attachment-a", "type": "clause", "offset": [137, 149]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [218, 251]}, {"key": "technical-documents", "type": "definition", "offset": [276, 295]}], "hash": "b9081af9f7ed8de02da48c6f1c84068c", "id": 6}, {"samples": [{"hash": "2PgN6oCi3Zx", "uri": "/contracts/2PgN6oCi3Zx#additional-technology", "label": "License Agreement (Targacept Inc)", "score": 20.0, "published": true}, {"hash": "1ZyCy8BNfnQ", "uri": "/contracts/1ZyCy8BNfnQ#additional-technology", "label": "License Agreement (Targacept Inc)", "score": 20.0, "published": true}], "snippet": "means inventions, discoveries, information, and know-how in the FIELD OF USE which may be developed under the Sponsored Research Agreement.", "size": 2, "snippet_links": [{"key": "field-of-use", "type": "definition", "offset": [64, 76]}, {"key": "sponsored-research-agreement", "type": "definition", "offset": [110, 138]}], "hash": "1f9ad41410b96a70c8659d163082681b", "id": 7}, {"samples": [{"hash": "drwqiotBa30", "uri": "/contracts/drwqiotBa30#additional-technology", "label": "Collaboration and License Agreement (Abgenix Inc)", "score": 21.0, "published": true}, {"hash": "10E0PZZYpNS", "uri": "/contracts/10E0PZZYpNS#additional-technology", "label": "Collaboration and License Agreement (Abgenix Inc)", "score": 21.0, "published": true}], "snippet": "means those Information and inventions that are Controlled by a Party that are necessary or reasonably useful to research and develop Antibodies and Antibody Equivalents that bind to and are directed against an Antigen and are in addition to the XenoMouse Technology and the Antibody Technology; provided, however, that Additional Technology shall exclude Antibody Technology, Antigen-Specific Technology, Collaboration Technology, Oncology Technology, Other Technology, Development Program Technology, Additional Development Program Technology, Process Technology and XenoMouse Technology.", "size": 2, "snippet_links": [{"key": "information-and-inventions", "type": "definition", "offset": [12, 38]}, {"key": "by-a-party", "type": "clause", "offset": [59, 69]}, {"key": "directed-against", "type": "definition", "offset": [191, 207]}, {"key": "in-addition-to-the", "type": "clause", "offset": [227, 245]}, {"key": "xenomouse-technology", "type": "clause", "offset": [246, 266]}, {"key": "antibody-technology", "type": "definition", "offset": [275, 294]}, {"key": "collaboration-technology", "type": "definition", "offset": [406, 430]}, {"key": "other-technology", "type": "clause", "offset": [453, 469]}, {"key": "development-program-technology", "type": "definition", "offset": [471, 501]}, {"key": "additional-development-program", "type": "definition", "offset": [503, 533]}, {"key": "process-technology", "type": "definition", "offset": [546, 564]}], "hash": "b2fc3777c06a6d0dcf6432ed296ee1a0", "id": 8}, {"samples": [{"hash": "2ZIje2dikM2", "uri": "/contracts/2ZIje2dikM2#additional-technology", "label": "Development Collaboration and Commercial License Agreement (Mersana Therapeutics, Inc.)", "score": 28.414100647, "published": true}, {"hash": "7nNtuHvo9o3", "uri": "/contracts/7nNtuHvo9o3#additional-technology", "label": "Development Collaboration and Commercial License Agreement (Mersana Therapeutics, Inc.)", "score": 28.2060241699, "published": true}], "snippet": "means (a) all Additional Know-How, and (b) any Patent Right that claims Additional Know-How.", "size": 2, "snippet_links": [{"key": "patent-right", "type": "definition", "offset": [47, 59]}], "hash": "8a164d31f7f33bd4324c002e480cd5ca", "id": 9}, {"samples": [{"hash": "gtOU6GOpmXi", "uri": "/contracts/gtOU6GOpmXi#additional-technology", "label": "Collaboration Agreement (Hyseq Inc)", "score": 18.0, "published": true}, {"hash": "ZiNiXKY8B6", "uri": "/contracts/ZiNiXKY8B6#additional-technology", "label": "Collaboration Agreement (Hyseq Inc)", "score": 18.0, "published": true}], "snippet": "shall have the meaning set forth in Section 3.5.1.", "size": 2, "snippet_links": [{"key": "section-351", "type": "clause", "offset": [36, 49]}], "hash": "7193d1e5220ecf59039115d2bdc18d3f", "id": 10}], "next_curs": "CmISXGoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIeYWRkaXRpb25hbC10ZWNobm9sb2d5IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "shall have the meaning set forth in Section 4.1(c).", "size": 38, "title": "Additional Technology", "id": "additional-technology", "examples": ["The aggregate purchase price for the Purchased Assets shall be equal to (i) the issuance to Seller of Five Million (5,000,000) shares of Parent\u2019s Series A-2 Preferred Stock (the \u201cIssued Shares\u201d), (ii) the Deferred Cash Consideration, and (iii) the <strong>Additional Technology</strong> Consideration, subject to adjustment pursuant to Section 2.06 hereof (the \u201cPurchase Price\u201d), plus the assumption of the Assumed Liabilities.", "S\u2587\u2587\u2587\u2587\u2587 agrees and acknowledges that any <strong>Additional Technology</strong> Consideration earned, if any, shall be considered part of the Purchase Price.", "If Buyer chooses to sell, license, or monetize any <strong>Additional Technology</strong>, any costs, including but not limited to filing and legal costs and fees, for maintaining the <strong>Additional Technology</strong> shall be deducted from the gross revenues received in such sale, license, or monetization prior to dividing the net proceeds pursuant to this Section 2.06(b).", "Notwithstanding anything herein to the contrary, S\u2587\u2587\u2587\u2587\u2587 agrees and acknowledges that nothing in this Agreement requires Buyer or any of its Affiliates to make any effort to maintain, sell, license, or monetize the <strong>Additional Technology</strong>."], "related": [["background-technology", "Background Technology", "Background Technology"], ["program-technology", "Program Technology", "Program Technology"], ["developed-technology", "Developed Technology", "Developed Technology"], ["collaboration-technology", "Collaboration Technology", "Collaboration Technology"], ["proprietary-technology", "Proprietary Technology", "Proprietary Technology"]], "related_snippets": [], "updated": "2026-02-25T05:25:33+00:00"}, "json": true, "cursor": ""}}